Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tibezonium iodide is a small molecule antiseptic and local anesthetic used primarily for the treatment of throat and mouth infections, including sore throat, pharyngitis, stomatitis, gingivitis, alveolitis, dental plaque, mouth sepsis, and halitosis. It is a quaternary ammonium salt with antibacterial properties that prevent microbial growth in the oral cavity. The drug acts locally by providing antiseptic effects and soothing inflammation in the mucous membranes of the mouth and throat. Tibezonium iodide belongs to the benzodiazepine class of organic compounds but is not used as a central nervous system agent; instead, its primary action is topical antimicrobial activity[1][2][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tibezonium iodide.